HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan Canaani Selected Research

Thiotepa (Triethylenethiophosphoramide)

10/2017Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan Canaani Research Topics

Disease

26Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2023 - 03/2016
18Leukemia
01/2022 - 01/2017
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2023 - 10/2017
4Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 10/2017
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2023 - 10/2016
3Inflammation (Inflammations)
06/2013 - 08/2008
2Neoplasms (Cancer)
06/2018 - 05/2008
2Carcinogenesis
06/2018 - 05/2008
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2013 - 08/2008
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
09/2023
1Thrombosis (Thrombus)
05/2023
1Cardiotoxicity
02/2021
1Wounds and Injuries (Trauma)
01/2021
1Left Ventricular Dysfunction
11/2019
1Multiple Myeloma
10/2019
1Chromosome Aberrations (Chromosome Abnormalities)
01/2019
1Residual Neoplasm
11/2018
1Philadelphia Chromosome
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
03/2016
1Lymphoma (Lymphomas)
04/2013
1Immune Reconstitution Inflammatory Syndrome
04/2013
1Anemia
02/2012
1Lymphadenopathy
02/2012
1Liver Diseases (Liver Disease)
08/2008
1Endometrial Hyperplasia
05/2008
1Carcinoma (Carcinomatosis)
05/2008
1Hyperplasia
05/2008
1Endometrial Neoplasms (Endometrial Cancer)
05/2008

Drug/Important Bio-Agent (IBA)

5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 10/2017
4gilteritinibIBA
09/2022 - 01/2019
2venetoclaxIBA
09/2023 - 01/2021
2AnthracyclinesIBA
02/2021 - 11/2019
2heparanaseIBA
06/2018 - 05/2008
1navitoclaxIBA
09/2023
1midostaurinIBA
01/2023
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2022
1fms-Like Tyrosine Kinase 3IBA
01/2022
1Pyridinolcarbamate (P23)IBA
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1bisantreneIBA
02/2021
1anthraceneIBA
02/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
06/2020
1Mitoxantrone (Novantrone)FDA LinkGeneric
06/2020
1PanobinostatIBA
10/2019
1treosulfanIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1fludarabineIBA
01/2019
1Transcription Factors (Transcription Factor)IBA
06/2018
1DNA (Deoxyribonucleic Acid)IBA
06/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1GlobulinsIBA
10/2017
1Immunoglobulins (Immunoglobulin)IBA
10/2017
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
10/2017
1Acetylcholine (Acetylcholine Chloride)FDA Link
06/2013
1Cholinergic Agents (Cholinergics)IBA
06/2013
1Rituximab (Mabthera)FDA Link
04/2013
1CytokinesIBA
06/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2012
1C-Reactive ProteinIBA
08/2008
1Biomarkers (Surrogate Marker)IBA
08/2008

Therapy/Procedure

15Transplantation
07/2023 - 01/2017
11Stem Cell Transplantation
01/2021 - 04/2017
7Hematopoietic Stem Cell Transplantation
07/2023 - 01/2017
6Drug Therapy (Chemotherapy)
09/2023 - 01/2021
5Induction Chemotherapy
10/2023 - 11/2019
5Cell Transplantation
11/2022 - 08/2017
5Therapeutics
02/2021 - 03/2016
2Salvage Therapy
09/2023 - 07/2023
2Haploidentical Transplantation
11/2018 - 01/2017
1Splenectomy
01/2021
1Traction
01/2021
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2021